Effect of 4-(N,N-dimethylamino)phenethyl Alcohol on Degree of Conversion and Cytotoxicity of Photo-Polymerized CQ-Based Resin Composites

The aim of this study was to evaluate the degree of conversion (DC) and the cytotoxicity of photo-cured experimental resin composites containing 4-(N,N-dimethylamino)phenethyl alcohol (DMPOH) combined to the camphorquinone (CQ) compared with ethylamine benzoate (EDAB). The resin composites were mechanically blended using 35 wt% of an organic matrix and 65 wt% of filler loading. To this matrix was added 0.2 wt% of CQ and 0.2 wt% of one of the reducing agents tested. 5x1 mm samples (n=5) were previously submitted to DC measurement and then pre-immersed in complete culture medium without 10% (v/v) bovine serum for 1 h or 24 h at 37 °C in a humidifier incubator with 5% CO2 and 95% humidity to evaluate the cytotoxic effects of experimental resin composites using the MTT assay on immortalized human keratinocytes cells. As a result of absence of normal distribution, the statistical analysis was performed using the nonparametric Kruskal-Wallis to evaluate the cytotoxicity and one-way analysis of variance to evaluate the DC. For multiple comparisons, cytotoxicity statistical analyses were submitted to Student-Newman-Keuls and DC analysis to Tukey's HSD post-hoc test (=0.05). No significant differences were found between the DC of DMPOH (49.9%) and EDAB (50.7%). 1 h outcomes showed no significant difference of the cell viability between EDAB (99.26%), DMPOH (94.85%) and the control group (100%). After 24 h no significant difference were found between EDAB (48.44%) and DMPOH (38.06%), but significant difference was found compared with the control group (p>0.05). DMPOH presented similar DC and cytotoxicity compared with EDAB when associated with CQ.

O objetivo deste estudo foi avaliar o grau de conversão (GC) e a citotoxicidade de resinas compostas experimentais utilizando o álcool 4-(N,N-dimetilamino) fenil etílico (DMPOH) associado à canforoquinona (CQ) como sistema fotoiniciador (SF) comparado à versão comercial utilizando o benzoato de etilamina (EDAB). Para tanto, as resinas compostas experimentais foram mecanicamente misturadas utilizando (em peso): 35% de matriz orgânica e 65% em peso de partículas de carga. Posteriormente, foram adicionados 0,2% de CQ e 0,2% de um dos agentes redutores testados. Amostras de 5 x 1 mm (n=5) foram previamentes submetidas à análise de GC e posteriormente, esterilizadas e colocadas no meio de cultura completo sem soro fetal bovino estéril por 1 h ou 24 h a 37 °C em encubadora com 5% de CO2 and 95% de umidade para avaliar os efeitos citotóxicos das resinas compostas experimentais utilizando o método MTT emcélulas células humanas imortalizadas de queratinócitos. Os dados de citotoxicidade foram submetidos à análise estatística de Kruskal-Wallis e de GC à análise de variância com um fator. Em virtude da ausência de normalidade, a análise estatística da citotoxicidade foi realizada utilizando-se o teste não-paramétrico de Kruskal-Wallis. Para o GC, os dados foram submetidos à análise de variaância de 1 fator. Posteriormente para múltiplas comparações, os dados de citotoxicidade foram submetidos ao teste Student-Newman-Keuls e o GC ao teste de Tukey's HSD post-hoc (=0.05). Não foi observada diferença estatística entre o GC de DMPOH (49,9%) e EDAB (50,7%). Para os resultados de 1 h não houve diferença na viabilidade celular entre EDAB (99,26%), DMPOH (94,85%) e o grupo controle (100%). Após 24 h, nenhuma diferença estatística foi encontrada entre EDAB (48,44%) e DMPOH (38,06%), entretanto, diferença significativa foi encontrada em relação ao grupo controle (p>0,05). O DMPOH apresentou GC e citotoxicidade semelhante à EDAB quando associado à CQ.

Ground reaction forces during level ground walking with body weight unloading

Background: Partial body weight support (BWS) systems have been broadly used with treadmills as a strategy for gait training of individuals with gait impairments. Considering that we usually walk on level ground and that BWS is achieved by altering the load on the plantar surface of the foot, it would be important to investigate some ground reaction force (GRF) parameters in healthy individuals walking on level ground with BWS to better implement rehabilitation protocols for individuals with gait impairments. Objective: To describe the effects of body weight unloading on GRF parameters as healthy young adults walked with BWS on level ground. Method: Eighteen healthy young adults (27±4 years old) walked on a walkway, with two force plates embedded in the middle of it, wearing a harness connected to a BWS system, with 0%, 15%, and 30% BWS. Vertical and horizontal peaks and vertical valley of GRF, weight acceptance and push-off rates, and impulse were calculated and compared across the three experimental conditions. Results: Overall, participants walked more slowly with the BWS system on level ground compared to their normal walking speed. As body weight unloading increased, the magnitude of the GRF forces decreased. Conversely, weight acceptance rate was similar among conditions. Conclusions: Different amounts of body weight unloading promote different outputs of GRF parameters, even with the same mean walk speed. The only parameter that was similar among the three experimental conditions was the weight acceptance rate. .

Clinicopathologic analysis of 57 cases of primary pulmonary mucinous adenocarcinoma / 中华肿瘤杂志

<p><b>OBJECTIVE</b>To summarize the clinicopathological characteristics and prognostic factors of primary pulmonary mucinous adenocarcinoma (PPMA).</p><p><b>METHODS</b>The clinicopathological manifestations and radiological appearances of 57 PPMA patients surgically treated and pathologically proved between Jan. 2001 and Dec. 2006 were retrospectively analyzed. The cumulated survival rate was calculated by life table method.</p><p><b>RESULTS</b>There were no specific clinical manifestations in PPMA patients, while the tumors were radiologically pleomorphologic. Of these 57 patients, 5 were in stage Ia, 20 in stage Ib, 1 in stage IIb, 11 in stage IIIa, 6 in stage IIIb and 14 in stage IV. The cumulated 1-, 3- and 5-year survivals of those with complete resection were 88.0%, 55.0% and 55.0%, respectively.</p><p><b>CONCLUSION</b>The final correct diagnosis of primary pulmonary mucinous adenocarcinoma should be made by pathology. Though the treatment is not different, the prognosis of the patients with primary pulmonary mucinous adenocarcinoma is better than that of those with adenocarcinoma.</p>

Down-regulation of lung resistance related protein by RNA interference targeting survivin induces the reversal of chemoresistances in hepatocellular carcinoma / 中华医学杂志(英文版)

<p><b>BACKGROUND</b>Both survivin and lung resistance related protein (LRP) are related to the chemoresistances in hepatocellular carcinoma (HCC). But the relationship between survivin and LRP is indefinite. The aim of this study was to investigate the effects of down-regulation of survivin on LRP expressions and the reversal of chemoresistances in HCC both in vitro and in vivo.</p><p><b>METHODS</b>The expressions of survivin were detected by RT-PCR and Western blotting in HCC cell line SMMC-7721 and SMMC-7721/ADM. The sensitivities of these two cell lines to ADM were evaluated by MTT assays. SiRNA which targeted survivin was transfected into SMMC-7721/ADM cells, then the sensitivity of SMMC-7721/ADM cells to ADM and the expressions of survivin and LRP were detected respectively. SMMC-7721/ADM cells were transplanted subcutaneously into nude mice to establish xenograft tumors. Antitumor activities of RNA interference (RNAi) targeting survivin, various doses of ADM and combination therapies were observed respectively. Possible toxicities were evaluated. LRP expression changes were tested. Student's t test was used for evaluating statistical significance.</p><p><b>RESULTS</b>The expressions of survivin in SMMC-7721/ADM cell line showed significant elevation compared to those in SMMC-7721 cell line (P < 0.05). Positive siRNA down-regulated the expressions of survivin significantly (P < 0.05). SiRNA targeting survivin could sensitize SMMC-7721/ADM cells to ADM and down-regulate the expressions of LRP significantly (P < 0.05). Growths of the tumors were significantly inhibited in positive siRNA group as compared with those in the control group from the 8th day (P < 0.05). Combination therapies caused significant tumor inhibitions compared with tumors of nude mice in the other three groups respectively (P < 0.05). No toxicities were found in nude mice treated by siRNA and combination therapies. The expressions of LRP were markedly reduced in tumors treated with siRNA targeting survivin (P < 0.05).</p><p><b>CONCLUSIONS</b>Down regulation of survivin gene by RNAi can increase chemosensitivity of HCC both in vitro and in vivo. The reversal of drug resistance may be reduced through the inhibitions of LRP.</p>

Anti-tumor effect of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with Bcl-2 expression / 中华胃肠外科杂志

<p><b>OBJECTIVE</b>To evaluate in vitro anti-tumor effect of chemotherapeutic drugs on human gastric cancer cells, and investigate the relationship with Bcl-2 expression.</p><p><b>METHODS</b>Single cell suspension was prepared from fresh gastric cancer tissue and exposed to taxol (Tax), 5-fluorouracil (5-FU), cisplatin (CDDP), adriamycin (ADM), mitomycin (MMC) respectively for 48 hours. Metabolic activity and inhibitory rate of cells were detected by MTT assay. Expression of Bcl-2 was examined with immunohistochemistry.</p><p><b>RESULTS</b>The inhibitory rates of cancer cells exposed to chemotherapeutic drugs were different and Tax, 5-FU, CDDP had remarkably higher rates than ADM and MMC. The lower differentiated gastric cancer cells were more sensitive than the higher ones. Positive expression rate of Bcl-2 was 80% and the positive cells showed resistance to 5-FU, ADM and MMC.</p><p><b>CONCLUSIONS</b>Chemosensitive testing by MTT assay can constitute the prediction for the application of chemotherapeutic drugs individually. Overexpression of Bcl-2 may contribute to multiple drug-resistance of tumors.</p>

In vitro antigenotoxicity of Ulva rigida C. Agardh (Chlorophyceae) extract against induction of chromosome aberration, sister chromatid exchange and micronuclei by mutagenic agent MMC / 生物医学与环境科学（英文）

<p><b>OBJECTIVE</b>To determine the in vitro possible clastogenic and cytotoxic activities of Ulva rigida crude extracts (URE), and identify their antigenotoxic and protective effects on chemotherapeutic agent mitomycine-C (MMC).</p><p><b>METHODS</b>Anti-clastogenic and anti-genotoxic activities of Ulva rigida crude extracts (URE) were studied using chromosome aberration (CA), sister chromatid exchange (SCE), and micronuclei (MN) tests in human lymphocytes cultured in vitro.</p><p><b>RESULTS</b>The chromosome aberration, sister chromatid exchange or micronuclei tests showed that URE at concentrations of 10, 20, and 40 microg/mL had no clastogenic activity in human lymphocyte cell culture. Three doses of URE significantly decreased the number of chromosomal aberrations and the frequencies of SCE and MN when compared with the culture treated with MMC (P < 0.0001).</p><p><b>CONCLUSION</b>Although URE itself is not a clastogenic or cytotoxic substance, it possesses strong antigenotoxic, anti-clastogenic, and protective effects on MMC in vitro.</p>

Expression of MDR1 and GST-pi in osteosarcoma and soft tissue sarcoma and their correlation with chemotherapy resistance / 中华肿瘤杂志

<p><b>OBJECTIVE</b>To explore the expression of multidrug resistance gene 1 ( MDR1), glutathione-S-transferases-pi (GST-pi) in osteosarcoma and soft tissue sarcoma tissues from 34 patients and their correlation with chemotherapy resistance.</p><p><b>METHODS</b>MDR1 and GST-pi expressions were analyzed by real-time fluorescence quantitative polymerase chain reaction (FQ-PCR) and flow cytometry (FCM) at mRNA and protein levels, respectively. Chemotherapy sensitivity on adriamycin, cisplatinum, fluorouracil, mitomycin C, dacarbazine, vincristine, methotrexate in tumor tissues were detected by MTT assay.</p><p><b>RESULTS</b>The nonsensitive rates on adriamycin, cisplatinum, fluorouracil, mitomycin C, dacarbazine, vincristine, methotrexate in tumor tissues were 41.18%, 17.7%, 47.1%, 50.0%, 76.5%, 61.8% and 52.9%, respectively. The expression of P-glycoprotein (P-gp) and GST-pi in tumor tissues was 1.54 and 2.58 (relative fluorescence intensity). Chi2 analysis showed that there was a positive correlation between P-gp expression and drug resistance on ADM, GST-pi expression and resistance on ADM, DDP and MMC (P < 0.05). There was not seen obvious correlation between expression of MDR1, GST-pi and age, gender, pathological type, tumor size in osteosarcoma and soft tissue sarcoma patients (P > 0.05). The expression of GST-pi was increased in patients receiving preoperative chemotherapy. The rate of postoperative recurrence was higher in patients with higher GST-pi expression level than those with lower GST-pi expression level before operation (P < 0.05).</p><p><b>CONCLUSION</b>Individual differences exist in chemotherapy sensitivity and expression of MDR1 and GST-pi in osteosarcoma and soft tissue sarcomas patients. Chemotherapy can induce up-regulation of GST-pi protein expression. Primary high expression of GST-pi is the main mechanism of resistance of osteosarcoma and soft tissue sarcomas to chemotherapy and is related to poor prognosis.</p>

Clinical study on treatment of advanced stage non-small cell lung cancer by guben xiaoliu capsule / 中国中西医结合杂志

<p><b>OBJECTIVE</b>To observe the therapeutic effect of Guben Xiaoliu Capsule (GXC) in treating advanced stage non-small cell lung cancer (NSCLC).</p><p><b>METHODS</b>One hundred and ninety-eight NSCLC in-patients were divided into the integrative treated group [Group A, 54 patients treated with chemotherapy (CT) plus GXC], the TCM treated group (Group B, 96 patients treated with GXC alone) and the chemotherapeutic group (Group C, 48 patients treated with CT alone). Randomized controlled observation was applied to the Group A and C. The clinical effect, quality of life (QOL), adverse reaction and survival period in the three groups were observed.</p><p><b>RESULTS</b>The immediate effective rate (CR + PR) in the Group A, B and C was 16.7%, 3.1% and 8.3%, respectively, in the Group A, it was better than that in the other two groups (P < 0.05). The improvement of clinical symptoms and QOL in the Group A and B were superior to those in the Group C (P < 0.05). The median survival rate in the three groups was 12, 15 and 9 months, respectively, the 1-, 2- and 3-year survival rate in Group A being 57.4%, 11.1% and 3.7%, respectively, in Group B, 67.7%, 9.4% and 3.1%, and in (Group C, 39.6%, 4.2% and 0, respectively, comparison between the three groups showed that the survival rates in the former two were higher than those in Group C (P < 0.05). Moreover, the incidence rate and degree of CT toxicity were milder in Group A than those in Group C (P < 0.05).</p><p><b>CONCLUSION</b>GXC has definite effect in treating NSCLC, it could raise the QOL, prolong the survival period of patients, also reduce the toxicity and enhance the efficacy of CT.</p>

Intraoperative adjuvant chemotherapy with mitomycin-C during pterygium surgery: a propspective phase II study

This study aimed to evaluate the efficacy of topical intermediate dose concentration [0.3 mg/ml] of mitomycin-C intraoperatively for a longer exposure time [5 minutes]on the recurrence rate, toxicity and the recurrence free survival. Between January 2000 and March 2003, pterygium excision has been performed for 19 eyes in 19patients with bare sclera technique, their median age was 42 years with male to female ratio of 2.2:1. Immediately after pterygium excision, topical mitomycin-C [0.3 mg/ml] was applied for 5 minutes over the bare scleral bed. One patient suffered a recurrence of pterygium in the area of previous excision during a median follow up of 20.5 months [range 3-39 months]. Pyogenic granuloma was reported in one patient and no other serious side effects were reported. The recurrence of pterygium occurred 18 months after excision and the 3-year recurrence free survival rate was 85%. The study concluded that single topical application of mitomycin-C 0.3 mg/ml for 5 minutes is safe and effective method to control recurrence of pterygium with minimal side effects than that reported with higher drug concentration. Further randomized studies to compare this technique with other methods is warranted to validate its efficacy

5-FU and mitomycin-C in conjunction with radiotherapy in patients with locally advanced pancreatic carcinoma

To evaluate the outcome of concomitant radiocemotherapy [RCT] in terms of treatment response, tolerability, possibility of subsequent surgical resection and survival in locally advanced pancreatic carcinoma. Twenty patients with locally advanced pancreatic carcinoma had been included in a prospective study. Patients had attended to Kas El Aini Center of Clinical Oncology and to the Menoufiya University Hospital and Liver institute, between September 1998 and December 2000. All patients were treated by RCT compirising 5400 cGy daily fractions of180 cGy 5 days a week, 5-Floruracil [5-FU] : 600mg/m2 by continuous intravenous infusion day 1-day 5 and Mitomycin-C': 10mg/m[2], i.v.-bolus day 2. Chemotherapy was repeated on day 29. patients were re-evaluated for the treatment outcome and the possibility of surgical resection 4 weeks after RCT Treatment response, toxicity and overall survival were the study end point. Twelve patients [60%] had decreased primary tumor size. Five cases appeared potentially respectable by CT and exp1plorative laparotomies were done but only four could be respected. The median survival of the study group was 10 months [range 4-21]. Themedian survival of patients who had undergone surgery was 19 ms [1421] response but appeared irresistible by the CT scan. The mediam survival of patients with stationary or progressive tumors was 6.5 ms [4-10]. The treatment applied in the study is feasible and have o significant acute toxicity. The respectability was improved but with no improvement of survival. Additional neoadjuvanl chemotherapy trials with new regimens may support the potential benefits of this line of treatmen

Endoscopic diode laser assisted inferior dacryocystorhinostomy with mitomycin C

To assess the efficacy of using diode laser and intraoperative mitomycin C in increasing the success rate of endoscopic DCR and to minimize the bone work by constituting a surgical window in the area of ultra thin lacrimal bone. Twenty-three patients diagnosed as having nasolacrimal duct obstruction were included in this study. Endoscopic diode laser assisted DCR with minimal bone work and with the use of MMC was done for all cases .At the end of six months 18 out of 23 patients [78.2%] were relieved of their symptoms completely, 2 patients showed incomplete improvement, while 3 patients [13.1%] continued to have persistent epiphora. The success rate was 86.9%. Turbino-nasal synechia formation occurred in one case [4.4%], Turbino-septal synechia formation and granulation tissue occurred in one case [4.4%] and granulation tissue only in one case [4.4%] endoscopic diode laser assisted DCR with minimal bone work and with the use of MMC in this series compares favorably with other techniques described in the literatures. This technique has the advantages of shortening operative time, decreasing the incidence of complications and good rate of success

Effect of astragalus injection combined with chemotherapy on quality of life in patients with advanced non-small cell lung cancer / 中国中西医结合杂志

<p><b>OBJECTIVE</b>To observe the effect of Astragalus injection (AI) combined with chemotherapy on quality of life (QOF) in patients with advanced non-small cell lung caner (NSCLC).</p><p><b>METHODS</b>Sixty-NSCLC patients were randomly divided into the treated group (n = 30, treated with AI combined with chemotherapy) and the control group (n = 30, treated with chemotherapy alone). Chemotherapy of MVP protocol was applied to both groups. AI was supplemented to the treated group by intravenous dripping 60 ml per day. Treatment of 21-28 days as one treatment cycle, and 2-3 treatment cycles were applied.</p><p><b>RESULTS</b>The effective rate in the treated group was 40.0% and in the control group was 36.7%, the mean remission rate in the treated and control group was 5.4 months and 3.3 months, the median survival period 11 months and 7 months, and the 1-year survival rate 46.75% and 30.0%, respectively, the differences of these indexes between the two groups were all significant (P < 0.05). Moreover, the clinical improving rate and QOF elevation rate in the treated group was 80.4% and 43.3%, as compared with those in the control group (50.0% and 23.3% respectively), the difference was also significant (P < 0.01).</p><p><b>CONCLUSION</b>AI combined with chemotherapy can significantly improve the QOF in NSCLC patients of advanced stage.</p>

Intracameral mitomycin and 5-FU to prevent posterior capsular opacity in rabbits

Purpose: To prevent the occurrence of secondary cataract after ECCE with PC-IOL implantation and evaluate the safety and effectiveness of Mitomycin C and 5-FU when used intraocular as an irrigating solution for its prevention in rabbits Materials and Methods: 15 rabbits were divided into 3 groups: Group A was given 5-50 mg/ml FU in 500 cc of BSS plus solution; Group B received MMC 0.2 percent mg/ml in 500 cc BSS; and Group C served as control with pure BSS. The study was done in accordance with the guidelines published by ARVO. The investigated drug solution was used as irrigating solution in cataract extraction performed in rabbits. Postoperatively, the rabbits examined under slit lamp from the 1st post op day and every 3 days thereafter. Their globes were enucleated 2 wks post op and 4 weeks post op, and sent to Pathology Laboratory for processing Results: Group A and Group B showed clear posterior capsule with no evidence of epithelial cell migration. Group C showed evidence of minimal to moderate epithelial cell migration and proliferation with fibrosis Conclusion: Mitomycin C (MMC) and 5-FU minimized and even prevented secondary cataract formation, with no effect on ocular structures when used as an irrigating solution.

Establishment of human multidrug-resistant lung carcinoma cell line (D6/MVP) / 中华肿瘤杂志

<p><b>OBJECTIVE</b>To establish human multidrug-resistant lung carcinoma cell line (D6/MVP) with its characteristics studied.</p><p><b>METHODS</b>Intermittent administration of high-dose MMC, VDS and DDP (MVP) was used to induce human lung carcinoma cell line (D6) to a multidrug-resistant variety (D6/MVP). MTT assay was used to study the multidrug resistance of D6/MVP to multianticarcinogen. Flow cytometry was used to study the cell cycle distribution and the expression of P-gp, multidrug resistance-associated protein (MRP) and GSH/GST.</p><p><b>RESULTS</b>1. D6/MVP was resistant to many anti-tumor agents, with the IC(50) 13.3 times higher and the drug resistance 2 - 6 times higher than D6, 2. The multiplication time of D6/MVP was prolonged and the cell number of S-phase decreased while that of G1- and G(2)-phase increased and 3. The expression of P-gp and MRP was enhanced significantly (96.2% vs 51.7%), but the expression of GSH/GST kept stable.</p><p><b>CONCLUSION</b>D6/MVP is a multidrug-resistant cell line possessing the basic characteristics of drug-resistance.</p>

Recuperação tardia de fístulas antiglaucomatosas pelo agulhamento episcleral associado à injeção subconjuntival de mitomicina / Late episcleral needling with adjunctive mitomicin-c for failed filtering blebs

Determinar a eficácia e a segurança do agulhamento episcleral, associado à injeção subconjuntival de mitomicina, na recuperação de fístulas no pós-operatório tardio de trabeculectomias. Local: Hospital Universitário Cassiano Antônio de Moraes - Universidade Federal do Espírito Santo. Métodos: Em trabalho prospectivo, foram tratados 61 olhos de 46 pacientes, com fístulas falidas, através do agulhamento episcleral associado à injeção subconjuntival de 5 a 10µg de mitomicina C, na borda posterior do retalho escleral. Foram tratados olhos com Po > 16mmHg, com medicação. Foi considerado sucesso a obtenção de níveis de Po < 15mmHg com ou sem medicação. Resultados: Sucesso foi obtido em 51 olhos (83,61 porcento), 39 (63,93 porcento) sem medicação e 12 (19,68 porcento) com medicação, sendo seis (9,84 porcento) com uma droga antiglaucomatosa e seis com duas drogas. Insucesso ocorreu em dez olhos (16,39 porcento). A Po média inicial, de 25,23 ± 7,72mmHg (variação de 16 a 45mmHg), antes do tratamento, caiu para 12,83 ± 6,52mmHg (variação de 6 a 40mmHg) no último controle. O número médio de drogas antiglaucomatosas tópicas antes do agulhamento, que era de 1,33 ± 1,03 (variação de zero a quatro), foi reduzido para 0,35 ± 0,69 (variação de zero a dois) após o mesmo. A acetazolamida, que era utilizada por nove pacientes, foi suspensa por todos. Quarenta e nove olhos foram submetidos a um agulhamento e 12 olhos a dois. No grupo de sucesso, o tempo de seguimento após o último agulhamento variou de seis a 24 meses, média de 11,30 ± 3,72 meses. Seis olhos tiveram hipotonia ocular duradoura após o agulhamento, sendo que quatro deles necessitaram de intervenção para sua correção. Conclusão: O agulhamento episcleral tardio, associado à injeção subconjuntival de mitomicina, mostrou-se eficaz e relativamente seguro na redução da Po em olhos com fístulas falidas, sendo muito mais simples e de custos muito menores que qualquer outro método cirúrgico.

Reversion mutation in dark variants of luminous bacteria and its application in gene toxicant monitoring / 华中科技大学学报（医学）（英德文版）

The luminous intensity of dark variant (S1) separated from photobacterium phosphoreum (A2) was 1/10,000 less than that of wild-type. Ethidium bromide (EB) (0.6 mg/L), Mytomycin C (MC, 0.05 mg/L), 2-amino fluorene (2-AF, 1.0 mg/L) all could strongly induce reversion mutation for S1 within 24 h and increase reversion ratio significantly. The results of experiments indicated that these revertants had stable genetic characteristic and the mutation may take place at gene levels. The mutagenesis to S1 caused by EB, MC and 2-AF was detected and it may be used as a new rapid, simple and sensitive method for gene toxicant monitoring.

Reversion mutation in dark variants of luminous bacteria and its application in gene toxicant monitoring / 华中科技大学学报（医学）（英德文版）

The luminous intensity of dark variant (S1) separated from photobacterium phosphoreum (A2) was 1/10,000 less than that of wild-type. Ethidium bromide (EB) (0.6 mg/L), Mytomycin C (MC, 0.05 mg/L), 2-amino fluorene (2-AF, 1.0 mg/L) all could strongly induce reversion mutation for S1 within 24 h and increase reversion ratio significantly. The results of experiments indicated that these revertants had stable genetic characteristic and the mutation may take place at gene levels. The mutagenesis to S1 caused by EB, MC and 2-AF was detected and it may be used as a new rapid, simple and sensitive method for gene toxicant monitoring.

Non-penetrating trabeculectomy with adjunctive mitomycin C in open angle glaucoma

The aim of this work was to evaluate and compare the results of non- penetrating trabeculectomy [NPT] alone or with the use of adjunctive mitomycin C [MMC] in primary open glaucoma. Twenty-eight eyes of 28 patients with uncontrolled primary open angle glaucoma were randomly assigned either to NPT alone [group 1] or with the application of MMC [group 2]. The cases were followed up for one-year. Success rate was defined as an intraocular pressure [IOP] of 21 mmHg or less without glaucoma medications. The rates of success at the final follow up period were 78.5% in the NPT without MMC [group 1] versus 92.8% in the NPT with MMC [group 2]. In conclusion, NPT with the application of MMC is an effective technique in controlling IOP in primary open angle glaucoma with avoiding the potential complications of standard trabeculectomy

Uso de la Milamicina C instalada, como profilaxis en la recurrencia de Pterigiones: en pacientes intervenidos quirúrgicamente en el Centro Nacional de Oftalmología

El presente estudio tiene como objetivo identificar el efecto de la Mitomicina C 0.02, instalada en el postoperatorio, en 20 pacientes escogidos al azar, con historias de 1 a 5 recurrrencias de pterigion. Los sujetosdel estudio se intervinieron entre los meses de septiembre y noviembre de 1998, con la técnica de escisión simple. En el primer día postoperatorio cada pacientes inició el uso de Mitomicina C al 0.02, una gota cada 8 horas, durante 5 días.El corte evaluativo se realizó cuando todos los pacientes tenían por lo menos 3 meses de intervenidos, 2 pacientes presentaron retardo en reepitelización conjuntiva durante las 2 primeras semanas de postoperatorio, que remitieron al final de este período. Dos pacientes presentaron recurrencia (10), teniendo estos las características de historia de más de una recidiva anterior, del grupo etáreo de25 a 34 años, además que fueron intervenido 1 año después de su ultima recurrencia. Se concluyó que el uso de Mitomicina C como porfilaxis en prevenir la recurrencia, es un método seguro y eficaz; y que los pacientes mas jovenes (grupo de 15 a 34 años), del sexo masculino, y con historia de más de recurrencia anterior, o recurrencia última de un año o menor, tienen mayor probalidad de enfrentar una nueva recidiva, aún con el uso de la profilaxis. Se recomendó preferir la técnica de escisión simple más la instalación postquirúrgica de Mitomicina C, a fin de evitar las recurrencias...

Histopatologia comparativa de las fístulas antiglaucomatosas / Comparative histopatology of antiglaucomatous blebs

Hemos examinado al microscopio 16 muestras de conjuntiva, excindidas por sindrome de hipotonia secundario a cirugía filtrante antiglaucomatosa. Los tres tipos de intervención practicadas: trabeculectomia simple, trabeculectomia con 5-FU y trabeculectomia con mitomicina parecen tener un substrato morfológico propio de cada una de ellas. El comportamiento del tejido conjuntivo (Tenon) en cada grupo es característico y determina finalmente el éxito o fracaso de la operación...